Diseases [C] » Cardiovascular Diseases [C14] » Vascular Diseases » Embolism and Thrombosis » Embolism
Description
Blocking of a blood vessel by an embolus which can be a blood clot or other undissolved material in the blood stream. MeSH
Hierarchy View
Subtype Terms (4)
Pulmonary Embolism
73 drugs (55 approved, 18 experimental)
Approved Indicated Drugs (2)
Phase 3 Indicated Drugs (4)
Phase 1 Indicated Drugs (1)
Organization Involved with Phase 4 Indications (105)
Ahi Evran University Education and Research Hospital
Azienda Ospedaliera Universitaria Policlinico
Canadian Institutes of Health Research (CIHR)
Cantonal Hospital of St. Gallen
Complejo Hospitalario Xeral Calde
Hospital Universitario Alvaro Cunqueiro
Hospital Virgen de la Victoria
Huazhong University of Science and Technology
Icahn School of Medicine at Mount Sinai
Imam Abdulrahman Bin Faisal University
Karadeniz Technical University
King Fahad Armed Forces Hospital
Medical University of South Carolina
National Heart, Lung, and Blood Institute (NHLBI)
Netherlands Organisation for Scientific Research
North Shore Hospital, New Zealand
People's Liberation Army of China
Polyclinique d'oncologie de Gentilly, Nancy, France
Silesian University of Medicine
St. Antonius Hospital, Nieuwegein
Thoracic & Cardiovascular Healthcare Foundation, Lansing, MI
Organization Involved with Phase 3 Indications (58)
Academic and Community Cancer Research United
Assistance Publique - Hôpitaux de Paris
Azienda U.S.L. 1 di Massa e Carrara
Cyclomedica Australia PTY Limited
Heart and Stroke Foundation of Canada
Holmes Regional Medical Center
Holy Name Medical Center, Teaneck, NJ
Lakeland Regional Medical Center
Life Sciences Research Partners (D Collen Research Foundation)
Medical Center of Central Georgia
Memorial Medical Center - Modesto
National Cancer Institute (NCI)
Ospedale S. Giovanni Bellinzona
Pirogov Russian National Research Medical University
Providence Memorial Hospital - Sierra Vista Hospital
R. Adams Cowley Shock Trauma Center
Organization Involved with Phase 2 Indications (31)
Organization Involved with Phase 1 Indications (7)
Organization Involved with Other Experimental Indications (23)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.